First approval of an intracranial stent in Japan
This article was originally published in The Gray Sheet
Executive Summary
Tokyo-based Johnson & Johnson/K.K. Medical Co. announces March 23 that Japan's Ministry of Health, Labor and Welfare has approved J&J/Codman's Enterprise vascularreconstruction device and delivery system. The self-expanding stent is used to treat wide-necked intracranial aneurysms. It marks the first approval for an intracranial stent by MHLW. Last year, J&J moved its central nervous system disorder device unit from its Cordis subsidiary to the Codman & Shurtleff unit (1"The Gray Sheet" Jan. 12, 2009)